The federal PHE (Public Health Emergency) ended on May 11, 2023; however, everything does not stop right away. For example, the Covid-19 Treatment Add-On Payment (NC-TAP) will continue until September 30, 2023. This includes the following:

  1. VEKLURY (remdesivir)
  2. Olumiant (baricitinib)
  3. Convalescent plasma
  4. Molnupiravir
  5. Paxlovid
  6. Kineret

In order to receive NCTAP, which is a 20-percent add-on payment, assign U07.1 for COVID-19 and the ICD-10-PCS code for the drug treatment.

The FY24 ICD-10-CM Official Coding Guidelines will be updated to state that code Z11.52, Encounter for screening for Covid-19, should be assigned for encounters for screening for COVID-19 infection. Until then, coding professionals should continue assigning Z20.822 when the documentation supports a negative COVID test result on the account.



PHE: The Beginning of the End; By Laurie M. Johnson, MS, RHIA, FAHIMA, AHIMA Approved ICD-10-CM/PCS Trainer; April 24, 2023

Coding Clinic, 1st QTR 2023